Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Emergent Biosolutions
(NY:
EBS
)
3.890
+0.590 (+17.88%)
Official Closing Price
Updated: 4:10 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Emergent Biosolutions
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
October 02, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Opioid Overdose Treatment: Walgreens To Stock FDA-Approved NARCAN Spray
August 30, 2023
Walgreens Boots Alliance Inc (NASDAQ: WBA) said
Via
Benzinga
Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency
August 30, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Why Emergent BioSolutions Stock Is Tumbling Today
August 22, 2023
The healthcare stock will soon be booted from an index tracked by several ETFs.
Via
The Motley Fool
Why Emergent BioSolutions Stock Dived by 9% Today
June 27, 2023
Investors didn't greet news of the CEO's departure warmly.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2023
August 29, 2023
Via
Benzinga
Why Macy's Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 22, 2023
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares jumped 42.8% to $5.60 after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease.
Via
Benzinga
Exposures
Product Safety
Why ProMIS Neurosciences Shares Are Trading Higher By 33%; Here Are 20 Stocks Moving Premarket
August 22, 2023
Gainers Axcella Health Inc. (NASDAQ: AXLA) shares gained 65% to $0.2887 in pre-market trading after gaining 12% on Monday. The company recently posted a narrower-than-expected quarterly loss.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
August 22, 2023
We're starting off Tuesday with a breakdown of the biggest pre-market stock movers investors will want to keep an eye on!
Via
InvestorPlace
PureCycle Technologies, Canadian Solar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
August 22, 2023
U.S. stock futures traded higher this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Emergent BioSolutions (EBS) Q2 2023 Earnings Call Transcript
August 09, 2023
EBS earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Emergent BioSolutions Reports Financial Results for Second Quarter 2023
August 08, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position
August 08, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Caterpillar, Oshkosh, AudioCodes And Other Big Stocks Moving Higher On Tuesday
August 01, 2023
U.S. stocks traded lower, with the Nasdaq Composite falling around 70 points on Tuesday. Here are some big stocks recording gains in today’s session. American Superconductor Corporation (NASDAQ: AMSC)...
Via
Benzinga
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 01, 2023
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
July 31, 2023
Via
Benzinga
Why Emergent Biosolutions Stock Is Surging After The Close
July 31, 2023
Emergent Biosolutions Inc (NYSE: EBS) shares are trading higher in Monday's after-hours session after the company was awarded a 10-year contract for
Via
Benzinga
Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola
July 31, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions to Release Second Quarter 2023 Financial Results and Conduct Conference Call on August 8, 2023
July 25, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Potential Delay In iPhone 15 Debut Could Impact Apple's Margins, Meta's Threads App Faces User Exodus, Microsoft CEO Satya Nadella's Earnings Exceed $1B: Today's Top Stories
July 21, 2023
New York Times
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
July 28, 2023
Friday's session saw 59 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 21, 2023
Via
Benzinga
Why Emergent BioSolutions Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket
July 21, 2023
Gainers BioNexus Gene Lab Corp (NASDAQ: BGLC) shares surged 50.1% to $7.31 in pre-market trading. BioNexus Gene Lab reported pricing of $5 million public offering and uplisting to the Nasdaq Capital...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 21, 2023
It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
Emergent BioSolutions' Two-Dose Anthrax Vaccine Secures FDA Nod; Shares Jump
July 21, 2023
The FDA approved Emergent BioSolutions Inc's (NYSE: EBS) anthrax vaccine for adults
Via
Benzinga
Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
July 20, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
July 05, 2023
Wednesday's session saw 43 companies set new 52-week lows.
Via
Benzinga
Emergent BioSolutions Announces CEO Transition
June 27, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Better Recovery-Story Buy: Emergent BioSolutions or Invitae?
June 26, 2023
Both of these stocks have plummeted more than 50% over the past year.
Via
The Motley Fool
Bavarian Nordic Beefs Up Chikungunya Vaccine Race With Valneva With Encouraging Late-Stage Trial Data
June 20, 2023
Bavarian Nordic A/S's (OTC: BVNRY) phase 3 chikungunya virus vaccine (CHIKV VLP (PXVX0317) clinical trial has hit its primary endpoint in
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.